The DOI matches its Crossref record.
Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression
Abstract
Opioids induce respiratory depression via activation of μ-opioid receptors at specific sites in the central nervous system including the pre-Bötzinger complex, a respiratory rhythm generating area in the pons. Full opioid agonists like morphine and fentanyl affect breathing with onset and offset profiles that are primarily determined by opioid transfer to the receptor site, while the effects of partial opioid agonists such as buprenorphine are governed by transfer to the receptor site together with receptor kinetics, in particular dissociation kinetics. Opioid-induced respiratory depression is potentially fatal but may be reversed by the opioid receptor antagonist naloxone, an agent with a short elimination half-life (30 min). The rate-limiting factor in naloxone-reversal of opioid effect is the receptor kinetics of the opioid agonists that requires reversal. Agents with slow dissociation kinetics (buprenorphine) require a continuous naloxone infusion while agents with rapid kinetics (fentanyl) will show complete reversal upon a single naloxone dose. Since naloxone is non-selective and will reverse analgesia as well, efforts are focused on the development of compounds that reverse opioid-induced respiratory depression without affecting analgesic efficacy. Such agents include ampakines and serotonin agonists which are aimed at selectively enhancing central respiratory drive. A novel approach is aimed at the reduction of respiratory depression from opioid-activation of (micro-)glia cells in the pons and brainstem using micro-glia cell stabilizers. Since this approach simultaneously enhances opioid analgesic efficacy it seems an attractive alternative to the classical reversal strategies with naloxone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Paul, A. K., Smith, C. M., Rahmatullah, M., Nissapatorn, V., Wilairatana, P., Spetea, M., Gueven, N., & Dietis, N. (2021) · Pharmaceuticals · doi:10.3390/ph14111091 · Cited by 300
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Shimada, I., Ueda, T., Kofuku, Y., Eddy, M. T., & Wüthrich, K. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.180 · Cited by 279
Opioid-induced fragile-like regulatory T cells contribute to withdrawal
Zhu, Y., Yan, P., Wang, R., Lai, J., Tang, H., Xiao, X., Yu, R., Bao, X., Zhu, F., Wang, K., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.030 · Cited by 73
A comprehensive review of partial opioid agonists for the treatment of chronic pain
Gress, K., Charipova, K., Jung, J. W., Kaye, A. D., Paladini, A., Varrassi, G., Viswanath, O., & Urits, I. (2020) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2020.06.003 · Cited by 36
Baker, A. K., & Garland, E. L. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000225 · Cited by 21
Metadata
- Authors
- Boom, M., Niesters, M., Sarton, E., Aarts, L., W. Smith, T., & Dahan, A.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-10-18
- Volume
- 18
- Issue
- 37
- Pages
- 5994-6004
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2140780197
- Cited by
- 252
- References
- 0
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression. https://app.cochat.ai/papers/10.2174/138161212803582469
- The paper
- Boom, M., Niesters, M., Sarton, E., Aarts, L., W. Smith, T., & Dahan, A. (2012). Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression. Current Pharmaceutical Design. https://doi.org/10.2174/138161212803582469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.